Allelic drop-out may occur with a primer binding site polymorphism for the commonly used RFLP assay for the -1131T>C polymorphism of the Apolipoprotein AV gene

Lipids in Health and Disease

Volumn 5, Issue , 2006, Pages

  Ward, Kirsten J ^a   Ellard, Sian ^a   Yajnik, Chittaranjan S ^b   Frayling, Timothy M ^a   Hattersley, Andrew T ^a   Venigalla, Prathyusha N S ^c   Chandak, Giriraj R ^c  

^a PENINSULA MEDICAL SCHOOL   (United Kingdom)

^b KEM HOSPITAL   (India)

^c CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A5; TRIACYLGLYCEROL;

ALLELE; ARTICLE; BINDING SITE; CONTROLLED STUDY; ETHNOLOGY; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HUMAN; MOLECULAR GENETICS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ALLELES; APOLIPOPROTEINS; APOLIPOPROTEINS A; BINDING SITES; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; GENE FREQUENCY; GENOTYPE; GREAT BRITAIN; HUMANS; INDIA; LINKAGE DISEQUILIBRIUM; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; QUALITY CONTROL;

TETRA;

EID: 33746271337     PISSN: 1476511X     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-5-11     Document Type: Article

References (30)

1. Pennacchio LA, Olivier M, Hubacek JA, Cohen JC, Cox DR, Fruchart JC, Krauss RM, Rubin EM: An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 2001, 294(5540):169-173.
2. van der Vliet HN, Sammels MG, Leegwater AC, Levels JH, Reitsma PH, Boers W, Chamuleau RA: Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration. J Biol Chem 2001, 276(48):44512-44520.
3. Martin S, Nicaud V, Humphries SE, Talmud PJ: Contribution of APOA5 gene variants to plasma triglyceride determination and to the response to both fat and glucose tolerance challenges. Biochim Biophys Acta 2003, 1637(3):217-225.
4. Weinberg RB, Cook VR, Beckstead JA, Martin DD, Gallagher JW, Shelness GS, Ryan RO: Structure and interfacial properties of human apolipoprotein A-V. J Biol Chem 2003.
5. Fruchart-Najib J, Bauge E, Niculescu LS, Pham T, Thomas B, Rommens C, Majd Z, Brewer B, Pennacchio LA, Fruchart JC: Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5. Biochem Biophys Res Commun 2004, 319(2):397-404.
6. Endo K, Yanagi H, Araki J, Hirano C, Yamakawa-Kobayashi K, Tomura S: Association found between the promoter region polymorphism in the apolipoprotein A-V gene and the serum triglyceride level in Japanese schoolchildren. Hum Genet 2002, 111(6):570-572.
7. Nabika T, Nasreen S, Kobayashi S, Masuda J: The genetic effect of the apoprotein AV gene on the serum triglyceride level in Japanese. Atherosclerosis 2002, 165(2):201-204.
8. Pennacchio LA, Olivier M, Hubacek JA, Krauss RM, Rubin EM, Cohen JC: Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet 2002, 11(24):3031-3038.
9. Ward KJ, Shields B, Knight B, Salzmann MB, Hattersley AT, Frayling TM: Genetic variants in Apolipoprotein AV alter triglyceride concentrations in pregnancy. Lipids Health Dis 2003, 2:9.
10. Bertolini S, Pisciotta L, Di Scala L, Langheim S, Bellocchio A, Masturzo P, Cantafora A, Martini S, Averna M, Pes G, et al.: Genetic polymorphisms affecting the phenotypic expression of familial hypercholesterolemia. Atherosclerosis 2004, 174(1):57-65.
11. Charlton-Menys V, Durrington PN: Apolipoprotein A5 and hypertriglyceridemia. Clin Chem 2005, 51(2):295-297.
12. Horinek A, Vrablik M, Ceska R, Adamkova V, Poledne R, Hubacek JA: T-1131→C polymorphism within the apolipoprotein AV gene in hypertriglyceridemic individuals. Atherosclerosis 2003, 167(2):369-370.
13. Kao JT, Wen HC, Chien KL, Hsu HC, Lin SW: A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia. Hum Mol Genet 2003, 12(19):2533-2539.
14. Schaefer JR, Sattler AM, Hackler B, Kurt B, Hackler R, Maisch B, Soufi M: Hyperlipidemia in patients with apolipoprotein E 2/2 phenotype: apolipoprotein A5 S19W mutation as a cofactor. Clin Chem 2004, 50(11):2214.
15. Vrablik M, Horinek A, Ceska R, Adamkova V, Poledne R, Hubacek JA: Ser19→Trp polymorphism within the apolipoprotein AV gene in hypertriglyceridaemic people. J Med Genet 2003, 40(8):e105.
16. Bi N, Yan SK, Li GP, Yin ZN, Chen BS: A single nucleotide polymorphism -1131T>C in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and alters triglyceride metabolism in Chinese. Mol Genet Metab 2004, 83(3):280-286.
17. Charlton-Menys V, Durrington PN: Apolipoprotein a5 and hypertriglyceridemia. Clin Chem 2005, 51(2):295-297.
18. Liu HK, Wang CT, Zhang SZ, Xiao CY, Li XF, Zhang KL, Zhang L, Su ZG, Ma YX, Zhou B, et al.: Association of APOA5 gene single nucleotide polymorphism with levels of lipids and coronary heart disease in Chinese. Zhonghua Yi Xue Yi Chaun Xue Za Zhi 2004, 21(4):335-338.
19. Baum L, Tomlinson B, Thomas GN: APOA5-1131T>C polymorphism is associated with triglyceride levels in Chinese men. Clin Genet 2003, 63(5):377-379.
20. Klos KL, Hamon S, Clark AG, Boerwinkle E, Liu K, Sing CF: APOA5 polymorphisms influence plasma triglycerides in young, healthy African Americans and whites of the CARDIA Study. J Lipid Res 2005, 46(3):564-571.
21. Ellard S, Bulman MP, Frayling TM, Allen LIS, Dronsfield MJ, Tack CJ, Hattersley AT: Allelic Drop-Out in Exon 2 of the Hepatocyte Nuclear Factor-1 alpha Gene Hinders the Identification of Mutations in Three Families With Maturity-Onset Diabetes of the Young. Diabetes 1999, 48:921-923.
22. Heinrich M, Muller M, Rand S, Brinkmann B, Hohoff C: Allelic drop-out in the STR system ACTBP2 (SE33) as a result of mutations in the primer binding region. Int J Legal Med 2004, 118(6):361-363.
23. Zajickova K, Krepelova A, Zofkova I: A single nucleotide polymorphism under the reverse primer binding site may lead to BsmI mis-genotyping in the vitamin D receptor gene. J Bone Miner Res 2003, 18(10):1754-1757.
24. Findlay I, Ray P, Quirke P, Rutherford A, Lilford R: Allelic drop-out and preferential amplification in single cells and human blastomeres: implications for preimplantation diagnosis of sex and cystic fibrosis. Hum Reprod 1995, 10(6):1609-1618.
25. Nelson MS, Levedakou EN, Matthews JR, Early BE, Freeman DA, Kuhn CA, Sprecher CJ, Amin AS, McElfresh KC, Schumm JW: Detection of a primer-binding site polymorphism for the STR locus D16S539 using the Powerplex 1.1 system and validation of a degenerate primer to correct for the polymorphism. J Forensic Sci 2002, 47(2):345-349.
26. Ye S, Humphries S, Green F: Allele specific amplification by tetra-primer PCR. Nucleic Acids Res 1992, 20(5):1152.
27. [http://cedar.genetics.soton.ac.uk/public_html/primer1.html].
28. Bavdekar A, Yajnik CS, Fall CH, Bapat S, Pandit AN, Deshpande V, Bhave S, Kellingray SD, Joglekar C: Insulin resistance syndrome in 8-year-old PCS children: small at birth, big at 8 years, or both? Diabetes 1999, 48:2422-2429.
29. Yajnik CS, Fall CH, Vaidya U, Pandit AN, Bavdekar A, Bhat DS, Osmond C, Hales CN, Barker DJ: Fetal growth and glucose and insulin metabolism in four-year-old PCS children. Diabetic Medicine 1995, 12:330-336.
30. Wilkin TJ, Metcalf BS, Murphy MJ, Kirkby J, Jeffery AN, Voss LD: The relative contributions of birth weight, weight change, and current weight to insulin resistance in contemporary 5-year-olds: the EarlyBird Study. Diabetes 2002, 51(12):3468-3472.